vap-a–gfp plasmid (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
vap-a–gfp plasmid
Vap A–Gfp Plasmid, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vap-a%E2%80%93gfp+plasmid/pmc06130944-538-20-26
Average 90 stars, based on 1 article reviews
Vap A–Gfp Plasmid, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vap-a%E2%80%93gfp+plasmid/pmc06130944-538-20-26
Average 90 stars, based on 1 article reviews
vap-a–gfp plasmid - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum"
Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum
Journal: The Journal of Biological Chemistry
doi: 10.1074/jbc.RA118.003725
Figure Legend Snippet: VAP-A is associated with type II NEI containing late endosomes. A and B, VAP-A–GFP-transfected FEMX-I cells were immunolabeled for SUN2 (A) or infected with Rab7–RFP baculovirus (B) and analyzed by CLSM. Area of a cross-section of NEI is magnified. A single x-y optical section is presented. C, FEMX-I cells expressing VAP-A–GFP and Rab7–RFP were analyzed by time-lapse video microscopy. Elapsed time is indicated in the top right corner. Arrowheads show the localization of VAP-A–GFP in SUN2-immunolabeled NEI (A), and arrows indicate Rab7–RFP+ late endosomes in NEI (B and C). Cartoon illustrates the direction (arrow) of Rab7+ late endosomes (LE) in NEI. D, cells expressing ER–GFP marker were double-immunolabeled for VAP-A and SUN2. A three-dimensional (3D) reconstruction of two adjacent sections (0.4-μm each) is presented. Only part of the nucleus is shown. Note the absence (purple arrow) or presence (yellow arrows) of VAP-A and ER–GFP in SUN2+ type I and II NEI, respectively. Additional information is provided in Fig. S1. E, percentage of SUN2+ NEI (type II) containing VAP-A or ER–GFP is presented. The means ± S.D. are shown (n = 3). The average of each experiment, where more than 50 cells were evaluated, is indicated. F, EM of FEMX-I cells shows that type II NEI are not only superficial indentations of the nuclear envelope but also appeared as deep recesses (yellow arrows). G and H, immunogold labeling on ultrathin cryosections reveals the presence of VAP-A–GFP in deep NEI of FEMX-I cells expressing the fusion protein (G, white arrowheads), whereas Rab7 proteins (H, black arrowheads) are found in the cytoplasm (left panel) and NEI (right panel) of FEMX-I cells. The presence of membrane-bound organelles in NEI is indicated with red arrowheads. nu, nucleoplasm. Scale bars, 5 μm (A–D) or as indicated (F–H).
Techniques Used: Transfection, Immunolabeling, Infection, Expressing, Microscopy, Marker, Labeling
Figure Legend Snippet: VAP-A is required for the entry of Rab7+ late endosomes in NEI. A–H, untransfected FEMX-I cells (control) or stably transfected with plasmids carrying scrambled shRNA, shVAP-A, or shVAP-B were analyzed by immunoblotting for VAP-A, VAP-B, and β-actin (A and E). Molecular mass markers (kDa) are indicated. Representative blots are shown. The relative VAP-A or VAP-B expression was quantified by comparison with control samples (B and F, red dotted line). The samples were normalized to β-actin. The means ± S.D. is shown with the individual value of each experience (n = 3). Alternatively, scrambled shRNA or shVAP-A/B transfected cells were infected with Rab7–RFP baculovirus and analyzed by CLSM after double-immunolabeling for VAP-A (C and D) or VAP-B (G and H) and SUN2. 3D reconstruction of 2–3 adjacent sections (0.4 μm each) is presented. Arrows indicate the presence of a given marker in NEI. Percentage of cells harboring either SUN2+ NEI-associated Rab7+ late endosomes, SUN2+ NEI only, or without NEI upon silencing VAP-A (D, see also Fig. S3) or VAP-B (H) were quantified. The means ± S.D. (D and H) are shown (n = 3). More than 50 cells were evaluated per experiment. p values are indicated. n.s., not significant. Images depicted in C are displayed in Videos S2 and S3. I, scrambled shRNA or shVAP-A–transfected FEMX-I cells were infected with ER–GFP and Rab7–RFP baculoviruses and analyzed by time-lapse video microscopy. Single x-y optical section (0.4 um) is presented. Elapsed time is indicated in the top right corner. Red and white arrows show the localization of Rab7–RFP in two distinct ER–GFP+ NEI (top, transverse section of NEI), and arrowheads indicate NEI without Rab7–RFP (bottom, sagittal section of three NEI). nu, nucleoplasm. Scale bars, 5 μm.
Techniques Used: Stable Transfection, Transfection, shRNA, Western Blot, Expressing, Infection, Immunolabeling, Marker, Microscopy
Figure Legend Snippet: ORP3 is essential for the entry of Rab7+ late endosomes in NEI and co-localized with VAP-A and Rab7. A and B, FEMX-I cells stably transfected with plasmids carrying scrambled shRNA or shVAP-A were immunolabeled for ORP3 and SUN2 prior to CLSM. Single x-y optical section is presented. The amount of SUN2+ NEI containing ORP3 (A, square, see insets at right) was quantified (B). C and D, scrambled shRNA- or shORP3-transfected cells were infected with Rab7–RFP baculovirus and analyzed by CLSM after double-immunolabeling for ORP3 and SUN2 (C). Percentage of cells harboring either SUN2+ NEI-associated Rab7+ late endosomes, SUN2+ NEI only, or without NEI upon silencing ORP3 were quantified (D). The means ± S.D. are shown (n = 3). More than 30 cells were evaluated per experiment, and their average is presented (B). p values are indicated. E and F, FEMX-I cells expressing VAP-A–GFP were double-immunolabeled for ORP3 and Rab7 prior to CLSM. Rab7 antibody was directly conjugated to fluorophore Alexa Fluor 647, and an anti-mouse secondary antibody coupled to TRITC was used to detect ORP3 (E). The inset shows the merged panel with a 4.0-μm-long arrow indicating the area subjected to line scan analysis with RFI of each channel (F). Thick line indicates the position of late endosomes in NEI where three fluorescent signals overlaid. In each panel, arrows show the localization of a given protein in NEI. Images depicted in C (top panels) are displayed in Video S4. nu, nucleoplasm. Scale bars, 5 μm.
Techniques Used: Stable Transfection, Transfection, shRNA, Immunolabeling, Infection, Expressing
Figure Legend Snippet: Tripartite complex of VAP-A, ORP3, and Rab7 in NEI. A and B, detergent lysates prepared from transfected FEMX-I cells expressing VAP-A–GFP (VAP-A–GFP+ FEMX-I) or untransfected cells (FEMX-I) were subjected to immunoisolation (IS) with either anti-GFP antibody-coupled magnetic beads or anti-ORP3 (A) or anti-VAP-B (B) antibody followed by protein G-coupled magnetic beads as indicated above each lane. An aliquot of the input (1:50) and the entire bound fractions were probed for ORP3, VAP-A/B, and Rab7 by immunoblotting. Molecular mass markers (kDa) are indicated. The antibody used is indicated in the top left corner of the blot. Arrows indicate the protein of interest, and the arrowhead indicates VAP-A–GFP protein. Representative blots are shown (n = 3–6). Note that the VAP-A–GFP expression level is similar to endogenous protein in VAP-A–GFP+ FEMX-I cells, and almost no VAP-B is co-immunoisolated with ORP3 in contrast to VAP-A.
Techniques Used: Transfection, Expressing, Magnetic Beads, Western Blot
Figure Legend Snippet: FRET analysis of the interaction between ORP3, VAP-A/B, and Rab7 in NEI. A–F, potential interactions between ORP3, VAP proteins, and Rab7 were evaluated by FRET using the acceptor photobleaching method. When appropriate, FEMX-I cells expressing VAP-A–GFP and/or Rab7–RFP were immunolabeled for ORP3 or VAP-B followed by secondary antibody coupled to appropriate fluorophore (TRITC or FITC). Intensity profiles and FRET efficiencies of each pair in NEI (A–D) or cytoplasm (E and F) are presented. The means ± S.D. are shown (n = 3). At least five cells were evaluated per experiment, and all of them are plotted. Acceptor photobleaching with a 561-nm laser line starts at time 15 s. FRET efficiencies were measured in a given ROI in bleached and unbleached areas. Corresponding micrographs with ROI are shown in Fig. S7.
Techniques Used: Expressing, Immunolabeling
Figure Legend Snippet: VOR complex is required for nuclear transfer of EV-derived proteins and nucleic acids. A and B, FEMX-I cells expressing either VAP-A–GFP (A) or ER–RFP (B) were incubated for 5 h with DiI-labeled EVs or CD9–GFP EVs, respectively, prior to analysis by time-lapse video microscopy. Elapsed time is indicated in the top right corner. Arrows indicate the entry of late endosomes containing DiI-labeled membranes (A) or CD9–GFP (B) in NEI and the arrowhead their tether to VAP-A–GFP+ ONM (A). GFP+ signals appearing in the nucleoplasm were highlighted (B, circles). Inset in B shows enlargement of NEI (dashed line) containing discrete punctate CD9–GFP signals. Still images (A) are from Video S5. C–E, scrambled shRNA (control, Ctl) or shVAP-A/B–transfected FEMX-I (C and D) or HeLa (E) cells were incubated with fluorescent EVs derived from CD9–GFP-expressing FEMX-I cells and then double-immunolabeled for VAP-A or VAP-B and SUN2 prior to CLSM. The amount of EV-derived CD9–GFP in the nuclear compartment was quantified using Fiji software. Micrographs are presented in Fig. S8. Independent values for each cell from three independent experiments (C, #1–3) and their average from three independent experiments (D and E) are presented. F and G, nuclei of FEMX-I cells incubated with CD9–GFP+ EVs were isolated before SUN2 immunolabeling and CLSM. Composite, single x-y section and z-projections are shown (F). GFP+ signals in the nucleoplasm were highlighted (circles) and quantified (G). H, scheme of isolation of EVs from FEMX-I cells and subsequent nucleic acid staining with SYTO 64 dye. I and J, scrambled shRNA or shVAP-A–transfected FEMX-I cells were incubated with SYTO 64-labeled EVs and immunolabeled as above. Nuclear SYTO 64 signals in a given cell (I, experiment #1) and their average from three independent experiments (J) were quantified. In all cases, means ± S.D. are shown (n = 3). More than 50 (C and D) and 30 (E, I, and J) cells or 30 isolated nuclei (G) were evaluated per experiment. p values are indicated. n.s., not significant. Scale bars, 5 μm.
Techniques Used: Derivative Assay, Expressing, Incubation, Labeling, Microscopy, shRNA, Transfection, Immunolabeling, Software, Isolation, Staining
Related Articles
Transfection:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Plasmid Preparation:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Immunolabeling:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Infection:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Expressing:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Microscopy:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Marker:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Labeling:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Stable Transfection:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with shRNA:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Western Blot:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Magnetic Beads:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Derivative Assay:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Incubation:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Software:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Isolation:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with Staining:Article Title: VAMP-associated protein-A and oxysterol-binding protein–related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum Article Snippet: Transfection FEMX-I cells were transfected with 10 μg of CD9–GFP plasmid using FuGENE® HD transfection reagents (Promega, Madison, WI) or VAP-A–GFP plasmid with |
